National and Kapodistrian University of Athens
Η επίδραση της χορήγησης συμπληρωμάτων ω-3 λιπαρών οξέων στη λειτουργικότητα των μεγάλων αρτηριών και στη λειτουργία του ενδοθηλίου σε άτομα με καρδιακή ανεπάρκεια ισχαιμικής αιτιολογίας
Abstract
dc:descriptionBackground: Heart failure (HF) is a syndrome characterized by disturbance of balance between proinflammatory and anti-inflammatory cytokines and its mortality is expected to grow over the coming decades. Endothelial dysfunction and increased arterial stiffness are observed in patients with heart failure and appear to be involved in the clinical manifestations and evolution of the syndrome. Omega-3 polyunsaturated fatty acids affect cardiovascular system with a multiplicity of mechanisms. Aim: In this study, we assessed the effects of Omega-3 PUFAs on inflammation, fibrosis, left ventricle performance and endothelial function of ischemic heart failure (HF) patients. Methods: We studied the effect of 8 weeks administration of omega-3 PUFAs in 31 patients with ischemic HF. The study was carried out on two separate arms, one with omega-3 polyunsaturated fatty acids and one with placebo (randomized, double-blind, cross-over design). Endothelial function was evaluated by flow mediated dilation (FMD) in the brachial artery. Left ventricle ejection fraction (EF), global longitudinal strain and the ratio E/e’ (early ventricular filling to early mitral annulus velocities) were measured. Myocardial fibrosis was evaluated by soluble ST2. Results: Treatment with omega-3 PUFA, compared to placebo, improved: left ventricle EF (percent increased by 4.7% vs 1.7%); global longitudinal strain (decreased by -10.6% vs -2.3%); the E/e’ ratio (decreased by -9.47% vs -2.1%); ST2 levels (decreased by -4.53% vs -2.37%); and flow mediated dilation (percent increased by 44% vs. 11%) (p<0.05 for all). Conclusion: Short term treatment with Omega-3 PUFAs in subjects with stable ischemic HF improved inflammatory and fibrotic status as well as systolic and diastolic performance of left ventricle, in parallel with endothelial function enhancement. These findings emphasize the beneficial mechanisms of Omega 3 PUFAs in patients with ischemic HF.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2019
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Karlis, Dimitrios
- Καρλής, Δημήτριος
Subjects
dc:subject × 11Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/45402